Parallax Volatility Advisers’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-13,900
| Closed | -$1.25M | – | 1887 |
|
|
2025
Q4 | $1.25M | Hold |
13,900
| – | – | ﹤0.01% | 1055 |
|
|
2025
Q3 | $1.37M | Hold |
13,900
| – | – | ﹤0.01% | 1039 |
|
|
2025
Q2 | $1.27M | Hold |
13,900
| – | – | ﹤0.01% | 1007 |
|
|
2025
Q1 | $1.57M | Sell |
13,900
-50,000
| -78% | -$5.35M | ﹤0.01% | 935 |
|
|
2024
Q4 | $6.75M | Buy |
+63,900
| New | +$6.86M | 0.01% | 712 |
|
|
2024
Q1 | – | Sell |
-11,400
| Closed | -$1.39M | – | 2453 |
|
|
2023
Q4 | $1.39M | Sell |
11,400
-6,300
| -36% | -$703K | ﹤0.01% | 1295 |
|
|
2023
Q3 | $1.99M | Sell |
17,700
-57,300
| -76% | -$7.28M | ﹤0.01% | 1098 |
|
|
2023
Q2 | $10.9M | Buy |
75,000
+74,300
| +10,614% | +$10.1M | 0.02% | 505 |
|
|
2023
Q1 | $90.4K | Buy |
+700
| New | +$87.9K | ﹤0.01% | 2147 |
|
|
2022
Q4 | – | Sell |
-3,000
| Closed | -$313K | – | 3328 |
|
|
2022
Q3 | $313K | Hold |
3,000
| – | – | ﹤0.01% | 2155 |
|
|
2022
Q2 | $317K | Hold |
3,000
| – | – | ﹤0.01% | 2073 |
|
|
2022
Q1 | $384K | Sell |
3,000
-2,768
| -48% | -$334K | ﹤0.01% | 1996 |
|
|
2021
Q4 | $713K | Sell |
5,768
-13,493
| -70% | -$1.77M | ﹤0.01% | 1360 |
|
|
2021
Q3 | $2.74M | Buy |
19,261
+14,523
| +307% | +$2.14M | ﹤0.01% | 1038 |
|
|
2021
Q2 | $739K | Buy |
4,738
+1,751
| +59% | +$284K | ﹤0.01% | 1074 |
|
|
2021
Q1 | $464K | Sell |
2,987
-72,512
| -96% | -$11.2M | ﹤0.01% | 965 |
|
|
2020
Q4 | $11.3M | Buy |
75,499
+29,561
| +64% | +$4.18M | 0.01% | 686 |
|
|
2020
Q3 | $6.07M | Sell |
45,938
-1,545
| -3% | -$202K | ﹤0.01% | 1220 |
|
|
2020
Q2 | $5.5M | Buy |
47,483
+19,982
| +73% | +$2.3M | 0.01% | 1038 |
|
|
2020
Q1 | $2.7M | Buy |
+27,501
| New | +$3.6M | ﹤0.01% | 1115 |
|
|
2019
Q1 | – | Sell |
-48,925
| Closed | -$4.93M | – | 4238 |
|
|
2018
Q4 | $4.93M | Hold |
48,925
| – | – | 0.01% | 712 |
|
|
2018
Q3 | $6.25M | Buy |
+48,925
| New | +$5.82M | 0.01% | 637 |
|
|
2017
Q4 | – | Sell |
-43,775
| Closed | -$4.98M | – | 5097 |
|
|
2017
Q3 | $4.98M | Hold |
43,775
| – | – | 0.01% | 569 |
|
|
2017
Q2 | $5.46M | Buy |
+43,775
| New | +$5.19M | 0.01% | 546 |
|
|
2016
Q1 | – | Sell |
-51,500
| Closed | -$5.13M | – | 3884 |
|
|
2015
Q4 | $5.13M | Hold |
51,500
| – | – | 0.01% | 676 |
|
|
2015
Q3 | $4.7M | Buy |
+51,500
| New | +$5.16M | 0.01% | 703 |
|
|
2014
Q4 | – | Sell |
-22,145
| Closed | -$2.16M | – | 6026 |
|
|
2014
Q3 | $2.16M | Buy |
+22,145
| New | +$2.18M | 0.01% | 1087 |
|
Other funds holding ZBH
VCM
VPM
Parallax Volatility Advisers's ZBH Position: Q1 2026 in Review
Parallax Volatility Advisers sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 13,551 shares — an estimated $1.22M sold.
Parallax Volatility Advisers first reported a position in ZBH in Q3 2014 and held it in 31 quarters. The position peaked at $3.05M in Q1 2019. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Parallax Volatility Advisers reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
- Parallax Volatility Advisers sold 13,551 Zimmer Biomet shares in Q1 2026, an estimated $1.22M.
- Parallax Volatility Advisers first reported a position in Zimmer Biomet in Q3 2014 and held it in 31 quarters.
- Parallax Volatility Advisers's Zimmer Biomet position peaked at $3.05M in Q1 2019.
- 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.